pd 135158 has been researched along with loxiglumide in 2 studies
Studies (pd 135158) | Trials (pd 135158) | Recent Studies (post-2010) (pd 135158) | Studies (loxiglumide) | Trials (loxiglumide) | Recent Studies (post-2010) (loxiglumide) |
---|---|---|---|---|---|
51 | 0 | 0 | 257 | 54 | 9 |
Protein | Taxonomy | pd 135158 (IC50) | loxiglumide (IC50) |
---|---|---|---|
Cholecystokinin receptor type A | Homo sapiens (human) | 0.195 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fölsch, UR; Höcker, M; Hughes, J; Schmidt, WE | 1 |
Blackmore, M; Doherty, E; Hirst, BH; Manning, JE | 1 |
2 other study(ies) available for pd 135158 and loxiglumide
Article | Year |
---|---|
PD 135158, a CCKB/gastrin receptor antagonist, stimulates rat pancreatic enzyme secretion as a CCKA receptor agonist.
Topics: Animals; Anti-Anxiety Agents; Cholecystokinin; Drug Interactions; Indoles; Lipase; Meglumine; Pancreas; Proglumide; Rats; Sincalide | 1993 |
Autocrine growth stimulation of human renal Wilms' tumour G401 cells by a gastrin-like peptide.
Topics: Benzamides; Benzodiazepinones; Cell Division; Devazepide; Gastrins; Humans; Indoles; Kidney Neoplasms; Meglumine; Phenylurea Compounds; Proglumide; Receptors, Cholecystokinin; Tumor Cells, Cultured; Wilms Tumor | 1994 |